BR0007174A - Compound, pharmaceutical preparation and use of compounds - Google Patents
Compound, pharmaceutical preparation and use of compoundsInfo
- Publication number
- BR0007174A BR0007174A BR0007174-9A BR0007174A BR0007174A BR 0007174 A BR0007174 A BR 0007174A BR 0007174 A BR0007174 A BR 0007174A BR 0007174 A BR0007174 A BR 0007174A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- compound
- pharmaceutical preparation
- preparation
- prodrugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
"COMPOSTO, PREPARAçãO FARMACêUTICA E USO DE COMPOSTOS". A invenção refere-se aos compostos de fórmula I e às suas formas tautoméricas, às suas possíveis formas diastereoméricas e enantioméricas, e às suas pró-drogas, à preparação e ao uso dos mesmos, os valores possuindo os significados indicados na descrição."COMPOUND, PHARMACEUTICAL PREPARATION AND USE OF COMPOUNDS". The invention relates to compounds of formula I and their tautomeric forms, their possible diastereomeric and enantiomeric forms, and their prodrugs, their preparation and use, the values having the meanings indicated in the description.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19946289A DE19946289A1 (en) | 1999-09-28 | 1999-09-28 | Benzodiazepine derivatives, their production and use |
DE10039610A DE10039610A1 (en) | 2000-08-09 | 2000-08-09 | Azepinoindole derivatives are PARP inhibitors and are useful for the treatment of neurodegenerative diseases, ischemia, tumor, septic shock, inflammation, rheumatic diseases, ARDS and diabetes mellitus |
PCT/EP2000/009024 WO2001023390A2 (en) | 1999-09-28 | 2000-09-15 | Azepinoindole derivatives, the production and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0007174A true BR0007174A (en) | 2001-09-04 |
Family
ID=26006691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0007174-9A BR0007174A (en) | 1999-09-28 | 2000-09-15 | Compound, pharmaceutical preparation and use of compounds |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1183259A2 (en) |
JP (1) | JP2003510328A (en) |
KR (1) | KR20010087401A (en) |
CN (1) | CN1374961A (en) |
AU (1) | AU1271201A (en) |
BG (1) | BG105650A (en) |
BR (1) | BR0007174A (en) |
CA (1) | CA2352194A1 (en) |
CZ (1) | CZ20012373A3 (en) |
HK (1) | HK1048999A1 (en) |
HU (1) | HUP0104917A3 (en) |
IL (1) | IL143349A0 (en) |
NO (1) | NO20012567L (en) |
PL (1) | PL347885A1 (en) |
SK (1) | SK8842001A3 (en) |
TR (1) | TR200101499T1 (en) |
WO (1) | WO2001023390A2 (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE261963T1 (en) | 1999-01-11 | 2004-04-15 | Agouron Pharma | TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES |
US7151102B2 (en) | 2000-10-30 | 2006-12-19 | Kudos Pharmaceuticals Limited | Phthalazinone derivatives |
JP4323802B2 (en) | 2000-12-01 | 2009-09-02 | エムジーアイ・ジーピー・インコーポレーテッド | Compounds and uses thereof |
US7026311B2 (en) * | 2002-01-10 | 2006-04-11 | Abbott Gmbh & Co., Kg | Dibenzodiazepine derivatives, their preparation and use |
JP4500161B2 (en) | 2002-04-30 | 2010-07-14 | クドス ファーマシューティカルズ リミテッド | Phthalazinone derivatives |
WO2004013333A2 (en) | 2002-07-26 | 2004-02-12 | Basf Plant Science Gmbh | Inversion of the negative-selective effect of negative marker proteins using selection methods |
US7449464B2 (en) | 2003-03-12 | 2008-11-11 | Kudos Pharmaceuticals Limited | Phthalazinone derivatives |
GB0305681D0 (en) | 2003-03-12 | 2003-04-16 | Kudos Pharm Ltd | Phthalazinone derivatives |
WO2005028467A1 (en) | 2003-09-15 | 2005-03-31 | Anadys Pharmaceuticals, Inc. | Antibacterial 3,5-diaminopiperidine-substitute aromatic and heteroaromatic compounds |
RU2413515C2 (en) | 2003-12-01 | 2011-03-10 | Кудос Фармасьютикалс Лимитед | Dna repair inhibitors for cancer therapy |
US8013006B2 (en) | 2004-07-14 | 2011-09-06 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
US7772271B2 (en) | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
JP2008507518A (en) | 2004-07-22 | 2008-03-13 | ピーティーシー セラピューティクス,インコーポレーテッド | Thienopyridine for treating hepatitis C |
EP2045327B8 (en) | 2005-03-08 | 2012-03-14 | BASF Plant Science GmbH | Expression enhancing intron sequences |
US7662824B2 (en) | 2005-03-18 | 2010-02-16 | Janssen Pharmaceutica Nv | Acylhydrazones as kinase modulators |
GB0521373D0 (en) | 2005-10-20 | 2005-11-30 | Kudos Pharm Ltd | Pthalazinone derivatives |
TWI404716B (en) | 2006-10-17 | 2013-08-11 | Kudos Pharm Ltd | Phthalazinone derivative |
AU2008299721A1 (en) | 2007-09-14 | 2009-03-19 | Astrazeneca Ab | Phthalazinone derivatives |
UY31603A1 (en) | 2008-01-23 | 2009-08-31 | DERIVATIVES OF FTALAZINONA | |
GB0804755D0 (en) * | 2008-03-14 | 2008-04-16 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
CN102238945B (en) | 2008-10-07 | 2014-10-29 | 阿斯利康(英国)有限公司 | Pharmaceutical formulation 514 |
WO2011058367A2 (en) | 2009-11-13 | 2011-05-19 | Astrazeneca Ab | Diagnostic test for predicting responsiveness to treatment with poly(adp-ribose) polymerase (parp) inhibitor |
CN102725412B (en) | 2009-11-27 | 2017-09-22 | 巴斯夫植物科学有限公司 | Endonuclease of optimization and application thereof |
EP2504430A4 (en) | 2009-11-27 | 2013-06-05 | Basf Plant Science Co Gmbh | Chimeric endonucleases and uses thereof |
CA2781693C (en) | 2009-11-27 | 2018-12-18 | Basf Plant Science Company Gmbh | Chimeric endonucleases and uses thereof |
NZ604035A (en) | 2010-06-04 | 2015-02-27 | Albany Molecular Res Inc | Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
EP3325623B3 (en) | 2015-07-23 | 2021-01-20 | Institut Curie | Use of a combination of dbait molecule and parp inhibitors to treat cancer |
GB201519573D0 (en) | 2015-11-05 | 2015-12-23 | King S College London | Combination |
WO2018162439A1 (en) | 2017-03-08 | 2018-09-13 | Onxeo | New predictive biomarker for the sensitivity to a treatment of cancer with a dbait molecule |
WO2018197461A1 (en) | 2017-04-28 | 2018-11-01 | Akribes Biomedical Gmbh | A parp inhibitor in combination with a glucocorticoid and/or ascorbic acid and/or a protein growth factor for the treatment of impaired wound healing |
CA3064761A1 (en) * | 2017-05-24 | 2018-11-29 | The Trustees Of The University Of Pennsylvania | Radiolabeled and fluorescent parp inhibitors for imaging and radiotherapy |
WO2019175132A1 (en) | 2018-03-13 | 2019-09-19 | Onxeo | A dbait molecule against acquired resistance in the treatment of cancer |
US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
EP3919495A4 (en) * | 2019-02-02 | 2022-10-19 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Indolo heptamyl oxime analogue as parp inhibitor |
WO2021018298A1 (en) * | 2019-08-01 | 2021-02-04 | 南京明德新药研发有限公司 | Indolo-seven-membered acyloxime compounds as parp inhibitors |
GB201913030D0 (en) | 2019-09-10 | 2019-10-23 | Francis Crick Institute Ltd | Treatment of hr deficient cancer |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
US20230331739A1 (en) * | 2020-07-31 | 2023-10-19 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Indolo heptamyl oxime analog crystal as parp inhibitor and method for preparing same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999011644A1 (en) * | 1997-09-03 | 1999-03-11 | Guilford Pharmaceuticals Inc. | Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity |
ATE261963T1 (en) * | 1999-01-11 | 2004-04-15 | Agouron Pharma | TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES |
ECSP003637A (en) * | 1999-08-31 | 2002-03-25 | Agouron Pharma | TRICYCLE POLY INHIBITORS (ADP-RIBOSA) POLYMERASES |
-
2000
- 2000-09-15 IL IL14334900A patent/IL143349A0/en unknown
- 2000-09-15 WO PCT/EP2000/009024 patent/WO2001023390A2/en not_active Application Discontinuation
- 2000-09-15 PL PL00347885A patent/PL347885A1/en not_active Application Discontinuation
- 2000-09-15 SK SK884-2001A patent/SK8842001A3/en unknown
- 2000-09-15 AU AU12712/01A patent/AU1271201A/en not_active Abandoned
- 2000-09-15 EP EP00974379A patent/EP1183259A2/en not_active Withdrawn
- 2000-09-15 BR BR0007174-9A patent/BR0007174A/en not_active IP Right Cessation
- 2000-09-15 HU HU0104917A patent/HUP0104917A3/en unknown
- 2000-09-15 JP JP2001526542A patent/JP2003510328A/en active Pending
- 2000-09-15 TR TR2001/01499T patent/TR200101499T1/en unknown
- 2000-09-15 CN CN00802408A patent/CN1374961A/en active Pending
- 2000-09-15 CA CA002352194A patent/CA2352194A1/en not_active Abandoned
- 2000-09-15 CZ CZ20012373A patent/CZ20012373A3/en unknown
- 2000-09-15 KR KR1020017006614A patent/KR20010087401A/en not_active Application Discontinuation
-
2001
- 2001-05-25 NO NO20012567A patent/NO20012567L/en not_active Application Discontinuation
- 2001-06-26 BG BG105650A patent/BG105650A/en unknown
-
2003
- 2003-02-18 HK HK03101179.8A patent/HK1048999A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1183259A2 (en) | 2002-03-06 |
IL143349A0 (en) | 2002-04-21 |
HK1048999A1 (en) | 2003-04-25 |
HUP0104917A3 (en) | 2002-12-28 |
SK8842001A3 (en) | 2002-01-07 |
NO20012567D0 (en) | 2001-05-25 |
PL347885A1 (en) | 2002-04-22 |
JP2003510328A (en) | 2003-03-18 |
TR200101499T1 (en) | 2002-09-23 |
WO2001023390A3 (en) | 2001-12-27 |
CN1374961A (en) | 2002-10-16 |
BG105650A (en) | 2002-02-28 |
NO20012567L (en) | 2001-06-25 |
KR20010087401A (en) | 2001-09-15 |
HUP0104917A2 (en) | 2002-04-29 |
AU1271201A (en) | 2001-04-30 |
CA2352194A1 (en) | 2001-04-05 |
CZ20012373A3 (en) | 2002-05-15 |
WO2001023390A2 (en) | 2001-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0007174A (en) | Compound, pharmaceutical preparation and use of compounds | |
BR0014326A (en) | Compound, medication, use of compounds, and process for preparing compounds | |
BR9914221B1 (en) | GLYCOPEPTIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
BR9911488A (en) | Compound, use of it, pharmaceutical composition, and processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound | |
BR0115452A (en) | Compounds having fungicidal activity and processes for their manufacture and use | |
DE60012188D1 (en) | Fungicides | |
PT1109812E (en) | PYRROLOBENZODIAZEPINAS | |
FI970067A (en) | 2 - [(dihydro) pyrazolyl-3'-oxymethylene / anilides as pesticides and fungicides | |
BR9713363A (en) | Epothilones c, d, e and f, preparation and compositions | |
BR9907300A (en) | Substituted oxoaza-heterocyclyl factor x inhibitors | |
BR9609022A (en) | Benzotriazoles of formula (I) process for the preparation of benzotriazoles of formula (I) micro-biocidal compositions use of benzotriazoles of formula (I) process to control undesirable microorganisms and process for the preparation of microbiocidal compositions | |
BR9711586A (en) | Compounds and their use | |
BR0112521A (en) | Indolquinazolinones | |
PT1009436E (en) | DERIVED FROM ACRIDINE TO INCREASE THE ORAL TAXOL BIODISPONIBILITY | |
BR0011831A (en) | Compounds, process for preparing them, pharmaceutical compositions, and, use of compounds | |
BR9911978A (en) | Substituted phenyluracils | |
SE9801494D0 (en) | Novel use | |
DZ2937A1 (en) | New compositions of insulin sensitizers. | |
BR9600339A (en) | Compounds pharmaceutical compositions process for the preparation of a compound and use thereof | |
IS5951A (en) | 5HT1 antidepressant for the treatment of depression | |
BR0114380A (en) | 1-Aminobutan-3-ol-substituted derivatives | |
BR0002505A (en) | 4-arylpiperidine derivatives for the treatment of pruritus | |
DK0750616T3 (en) | Acid addition salts of 2,3,4,5-tetrahydro-1H-3-benzazapine compounds | |
BR9808923A (en) | Compound, and, process to do the same | |
BR9814495A (en) | Compound, process to prepare it, use of it, pharmaceutical composition, and, process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 3A, 4A, 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1925 DE 27/11/2007. |